Robust Product Pipeline

Our rich pipeline of product candidates demonstrates our leadership in drug development for central nervous system (CNS) diseases, a therapeutic area where we have a proven track record of success. Backed by decades of experience, we are able to streamline clinical development time and substantially increase the probability of late-stage product success. The proof is in our substantial pipeline and its potential to have a unique and positive impact for patients.

Alkermes CNS Drug Development Pipeline Product Candidates

*Transition from physical dependence on opioids to VIVITROL®

Learn more about our portfolio of innovative products.